stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Ascendis Pharma A SASND
$248.830.97%-2.44
Dopo l'orario di chiusura: 248.98+0.15 +0.06%

Ascendis Pharma A S (ASND)

Date: 2026-11-02 16:00O: 252.55H: 254.62L: 248.68C: 248.83Vol: 408.9k
Precedente Chiudi:
$251.27
Aprire:
$252.55
Volume 24 ore:
408,944
Volume relativo:
0.77
Capitalizzazione di mercato:
$16.37B
Reddito:
$1.01B
Utile/perdita netta:
$581.90M
Rapporto P/E:
28.04
EPS:
$8.87
Flusso di cassa netto:
$50.57M
1W Prestazione:
+1.50%
1M Prestazione:
+9.20%
6M Prestazione:
+12.63%
1Y Prestazione:
+23.43%
Intervallo 1D:
$248.68$254.62
Intervallo di 1 settimana:
$243.45$255.61
Portata 52W:
$188.07$282.15

Profilo aziendale di Ascendis Pharma A S (ASND)

Nome
Ascendis Pharma A S
Settore
Healthcare
Industria
Biotechnology
Telefono
-
Indirizzo
Denmark
Dipendente
1,189
X
-
Prossima data di guadagno
2026-11-11
Ultimi documenti SEC
SEC
Discussioni di ASND su X
X

Confronta ASND con VRTX, REGN, MRNA, ARGX, ONC

AzioniCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
ASND
Ascendis Pharma A S
$16.37B$1.01B$581.90M$50.57M$8.87
VRTX
Vertex Pharmaceuticals Inc
$140.94B$12.59B$4.41B$3.80B$16.87
REGN
Regeneron Pharmaceuticals Inc
$99.46B$16.90B$4.82B$3.83B$41.04
MRNA
Moderna Inc
$88.17B$2.23B-$3.15B-$1.24B-$8.15
ARGX
Argen X Se Adr
$55.03B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$40.86B$6.13B$655.71M$1.33B$4.48

Ascendis Pharma A S Azioni (ASND) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-09-15DowngradeRaymond JamesStrong Buy → Outperform
2026-08-27IniziatoH.C. WainwrightBuy
2026-08-19IniziatoBMO Capital MarketsOutperform
2026-05-19IniziatoCitigroupBuy

Ascendis Pharma A S Azioni (ASND) Dati Finanziari

Non sono disponibili dati finanziari per Ascendis Pharma A S (ASND). Controlla altri titoli per ulteriori informazioni.

Ascendis Pharma A S Azioni (ASND) insider trading

  • Bodenhoff MadsSep 08 '26
    SVP & PAO
    Transazione
    Option Exercise
    Costo
    $110.00
    #Azioni
    3,000
    Valore ($)
    330,000
    #Azioni Totale
    3,000
  • Bodenhoff MadsSep 08 '26
    SVP & PAO
    Transazione
    Sale
    Costo
    $270.19
    #Azioni
    3,000
    Valore ($)
    810,570
    #Azioni Totale
    0
  • Bodenhoff MadsSep 08 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $270.19
    #Azioni
    3,000
    Valore ($)
    810,563
    #Azioni Totale
    0
  • HOLTUG LARSSep 02 '26
    Director
    Transazione
    Sale
    Costo
    $264.13
    #Azioni
    236
    Valore ($)
    62,335
    #Azioni Totale
    4,000
  • HOLTUG LARSSep 02 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $264.13
    #Azioni
    236
    Valore ($)
    62,335
    #Azioni Totale
    0
  • Director
    Transazione
    Buy
    Costo
    $246.33
    #Azioni
    2,000
    Valore ($)
    492,654
    #Azioni Totale
    2,900
  • EVP & Chief Financial Officer
    Transazione
    Buy
    Costo
    $219.00
    #Azioni
    100
    Valore ($)
    21,900
    #Azioni Totale
    4,367
  • Director
    Transazione
    Buy
    Costo
    $223.12
    #Azioni
    500
    Valore ($)
    111,562
    #Azioni Totale
    900
  • EVP & Chief Financial Officer
    Transazione
    Buy
    Costo
    $223.32
    #Azioni
    250
    Valore ($)
    55,830
    #Azioni Totale
    4,267
  • Director
    Transazione
    Buy
    Costo
    $237.80
    #Azioni
    400
    Valore ($)
    95,120
    #Azioni Totale
    400
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Bodenhoff MadsSVP & PAOSep 08 '26Option Exercise$110.003,000330,0003,000
Bodenhoff MadsSVP & PAOSep 08 '26Sale$270.193,000810,5700
Bodenhoff MadsOfficerSep 08 '26Proposed Sale$270.193,000810,5630
HOLTUG LARSDirectorSep 02 '26Sale$264.1323662,3354,000
HOLTUG LARSDirectorSep 02 '26Proposed Sale$264.1323662,3350
BIENAIME JEAN JACQUESDirectorAug 14 '26Buy$246.332,000492,6542,900
SMITH SCOTT THOMASEVP & Chief Financial OfficerJun 02 '26Buy$219.0010021,9004,367
BIENAIME JEAN JACQUESDirectorMay 29 '26Buy$223.12500111,562900
SMITH SCOTT THOMASEVP & Chief Financial OfficerMay 29 '26Buy$223.3225055,8304,267
BIENAIME JEAN JACQUESDirectorMay 26 '26Buy$237.8040095,120400

Ascendis Pharma A S Borsa (ASND) Ultime notizie

Oct 21, 2026
Oct 21, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 17, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 15, 2026
Oct 14, 2026
Oct 14, 2026
Oct 07, 2026
Oct 07, 2026
Oct 05, 2026
Oct 05, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 21, 2026
Sep 21, 2026
Sep 20, 2026
Sep 20, 2026
Sep 17, 2026
Sep 17, 2026
Sep 15, 2026
Sep 15, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 12, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 10, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 07, 2026
Sep 07, 2026
Sep 07, 2026
Sep 07, 2026

Simile a ASND